207 related articles for article (PubMed ID: 33176870)
21. Effect of adjunctive intermittent theta-burst repetitive transcranial magnetic stimulation as a prophylactic treatment in migraine patients: A double-blind sham-controlled study.
Sahu AK; Sinha VK; Goyal N
Indian J Psychiatry; 2019; 61(2):139-145. PubMed ID: 30992607
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.
Sun H; Dodick DW; Silberstein S; Goadsby PJ; Reuter U; Ashina M; Saper J; Cady R; Chon Y; Dietrich J; Lenz R
Lancet Neurol; 2016 Apr; 15(4):382-90. PubMed ID: 26879279
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of repetitive transcranial magnetic stimulation (rTMS) for young individuals with high-level perceived stress: study protocol for a randomized sham-controlled trial.
Wu J; Han M; He Y; Xie X; Song J; Geng X
Trials; 2021 May; 22(1):365. PubMed ID: 34034790
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of cathodal tDCS of the primary motor or sensory cortex in migraine: A randomized controlled trial.
Rahimi MD; Fadardi JS; Saeidi M; Bigdeli I; Kashiri R
Brain Stimul; 2020; 13(3):675-682. PubMed ID: 32289696
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Effects of Self-Administered Transcranial Direct Current Stimulation in Episodic Migraine Prevention: Results of a Randomized Controlled Trial.
Pohl H; Moisa M; Jung HH; Brenner K; Aschmann J; Riederer F; Ruff CC; Schoenen J; Luechinger R; Widmer L; Petersen JA; Gantenbein AR; Sandor PS; Michels L
Neuromodulation; 2021 Jul; 24(5):890-898. PubMed ID: 33078518
[TBL] [Abstract][Full Text] [Related]
26. The effects of repetitive transcranial magnetic stimulation on body weight and food consumption in obese adults: A randomized controlled study.
Kim SH; Chung JH; Kim TH; Lim SH; Kim Y; Eun YM; Lee YA
Brain Stimul; 2019; 12(6):1556-1564. PubMed ID: 31378600
[TBL] [Abstract][Full Text] [Related]
27. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
Young W; Shaw J; Bloom M; Gebeline-Myers C
Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
[TBL] [Abstract][Full Text] [Related]
28. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
Dodick DW; Silberstein SD; Bigal ME; Yeung PP; Goadsby PJ; Blankenbiller T; Grozinski-Wolff M; Yang R; Ma Y; Aycardi E
JAMA; 2018 May; 319(19):1999-2008. PubMed ID: 29800211
[TBL] [Abstract][Full Text] [Related]
29. Long-term prophylactic efficacy of transcranial direct current stimulation in chronic migraine. A randomised, patient-assessor blinded, sham-controlled trial.
Hodaj H; Payen JF; Mick G; Vercueil L; Hodaj E; Dumolard A; Noëlle B; Delon-Martin C; Lefaucheur JP
Brain Stimul; 2022; 15(2):441-453. PubMed ID: 35219923
[TBL] [Abstract][Full Text] [Related]
30. Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial.
Goadsby PJ; Dodick DW; Ailani J; Trugman JM; Finnegan M; Lu K; Szegedi A
Lancet Neurol; 2020 Sep; 19(9):727-737. PubMed ID: 32822633
[TBL] [Abstract][Full Text] [Related]
31. A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients.
George MS; Raman R; Benedek DM; Pelic CG; Grammer GG; Stokes KT; Schmidt M; Spiegel C; Dealmeida N; Beaver KL; Borckardt JJ; Sun X; Jain S; Stein MB
Brain Stimul; 2014; 7(3):421-31. PubMed ID: 24731434
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the improvement of fatigue in fibromyalgia: A 4-week left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation randomized-controlled trial.
Fitzgibbon BM; Hoy KE; Knox LA; Guymer EK; Littlejohn G; Elliot D; Wambeek LE; McQueen S; Elford KA; Lee SJ; Enticott PG; Fitzgerald PB
Eur J Pain; 2018 Aug; 22(7):1255-1267. PubMed ID: 29542208
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
Dodick DW; Goadsby PJ; Silberstein SD; Lipton RB; Olesen J; Ashina M; Wilks K; Kudrow D; Kroll R; Kohrman B; Bargar R; Hirman J; Smith J;
Lancet Neurol; 2014 Nov; 13(11):1100-1107. PubMed ID: 25297013
[TBL] [Abstract][Full Text] [Related]
34. High frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex for methamphetamine use disorders: A randomised clinical trial.
Su H; Zhong N; Gan H; Wang J; Han H; Chen T; Li X; Ruan X; Zhu Y; Jiang H; Zhao M
Drug Alcohol Depend; 2017 Jun; 175():84-91. PubMed ID: 28410525
[TBL] [Abstract][Full Text] [Related]
35. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Bigal ME; Edvinsson L; Rapoport AM; Lipton RB; Spierings EL; Diener HC; Burstein R; Loupe PS; Ma Y; Yang R; Silberstein SD
Lancet Neurol; 2015 Nov; 14(11):1091-100. PubMed ID: 26432181
[TBL] [Abstract][Full Text] [Related]
36. Repetitive transcranial magnetic stimulation of the left premotor/dorsolateral prefrontal cortex does not have analgesic effect on central poststroke pain.
de Oliveira RA; de Andrade DC; Mendonça M; Barros R; Luvisoto T; Myczkowski ML; Marcolin MA; Teixeira MJ
J Pain; 2014 Dec; 15(12):1271-81. PubMed ID: 25267523
[TBL] [Abstract][Full Text] [Related]
37. The effects of repetitive transcranial magnetic stimulation on eating behaviors and body weight in obesity: A randomized controlled study.
Kim SH; Chung JH; Kim TH; Lim SH; Kim Y; Lee YA; Song SW
Brain Stimul; 2018; 11(3):528-535. PubMed ID: 29326022
[TBL] [Abstract][Full Text] [Related]
38. Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients.
Prikryl R; Ustohal L; Kucerova HP; Kasparek T; Jarkovsky J; Hublova V; Vrzalova M; Ceskova E
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():30-5. PubMed ID: 24211840
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Tepper S; Ashina M; Reuter U; Brandes JL; Doležil D; Silberstein S; Winner P; Leonardi D; Mikol D; Lenz R
Lancet Neurol; 2017 Jun; 16(6):425-434. PubMed ID: 28460892
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of high-frequency (15Hz) repetitive transcranial magnetic stimulation (rTMS) of the left premotor cortex/dorsolateral prefrontal cortex in decreasing cocaine intake (the MagneTox study): A study protocol for a randomized placebo-controlled pilot trial.
Scarpino M; Lanzo G; Salimova M; Lolli F; Del Vecchio A; Cossu C; Bastianelli M; Occupati B; Lanzi C; Pallanti S; Amantini A; Mannaioni G; Grippo A
Neurophysiol Clin; 2019 Feb; 49(1):1-9. PubMed ID: 30712533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
